Library Item - Page 28 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Evaluating COVID-19 vaccination in immunocompromised patients with blood cancers

Evaluating COVID-19 vaccination in immunocompromised patients with blood cancers

Posted by on May 31, 2022 in Hodgkin's lymphoma | 0 comments

In a nutshell The study aimed to investigate if immunocompromised patients with blood cancers benefit from COVID-19 vaccination.  This study concluded that these patients should not be excluded from COVID-19 vaccination.  Some background Patients with blood cancers are at high risk for severe forms of COVID-19 disease due to lower...

Read More

Comparing the effectiveness of surgery with and without oral uracil and tegafur plus leucovorin chemotherapy for patients with stage II colon cancer.

Comparing the effectiveness of surgery with and without oral uracil and tegafur plus leucovorin chemotherapy for patients with stage II colon cancer.

Posted by on May 31, 2022 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of surgery with and without chemotherapy with uracil and tegafur (Uftoral; UFT) plus leucovorin (LV; folinic acid) in patients with stage II colon cancer. This study concluded that surgery with UFT/LV chemotherapy significantly improved survival outcomes in these patients. Some...

Read More

Evaluating the effectiveness and safety of 225Ac-PSMA-617 after treatment with androgen deprivation therapy in patients with metastatic castration-resistant prostate cancer.

Evaluating the effectiveness and safety of 225Ac-PSMA-617 after treatment with androgen deprivation therapy in patients with metastatic castration-resistant prostate cancer.

Posted by on May 31, 2022 in Prostate cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of actinium-225 [225Ac]-PSMA-617 (225AcPSMA) after treatment with androgen deprivation therapy (ADT) in patients with metastatic castration-resistant prostate cancer (mCRPC). The data showed that 225AcPSMA treatment showed a higher response with manageable effects in these patients. Some...

Read More

Evaluating the effectiveness and safety of first-line tyrosine kinase inhibitor with or without radiotherapy for the treatment of patients with oligometastatic EGFR-mutated NSCLC.

Evaluating the effectiveness and safety of first-line tyrosine kinase inhibitor with or without radiotherapy for the treatment of patients with oligometastatic EGFR-mutated NSCLC.

Posted by on May 31, 2022 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of first-line tyrosine kinase inhibitors (TKIs) with or without radiotherapy (RT) for the treatment of patients with oligometastatic (OM) non-small-cell lung cancer (NSCLC) having genetic mutations in the epidermal growth factor receptor (EGFR). The data showed that TKI plus RT was safe and...

Read More

Evaluating the effectiveness of antiresorptive drugs on bone mineral density in postmenopausal women with early-stage breast cancer receiving treatment with aromatase inhibitors.

Evaluating the effectiveness of antiresorptive drugs on bone mineral density in postmenopausal women with early-stage breast cancer receiving treatment with aromatase inhibitors.

Posted by on May 31, 2022 in Breast cancer | 0 comments

In a nutshell This study evaluated the effectiveness of antiresorptive drugs on bone mineral density (BMD) in postmenopausal women with early-stage breast cancer (BC) receiving treatment with aromatase inhibitors (AIs). The data showed that denosumab (Prolia) and zoledronic acid (Aclasta) were the most effective antiresorptive treatment options to...

Read More

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study observed the effectiveness of a ketogenic diet (KD) in patients newly diagnosed with type 2 diabetes (T2D) that were overweight or obese. The authors concluded that a DK can control body weight, blood glucose, and blood lipids (fats) in these patients but long-term adherence is a challenge. Some background...

Read More

How safe and well-tolerated is high-dose daily administration of vitamin D3 supplementation in persons with prediabetes?

How safe and well-tolerated is high-dose daily administration of vitamin D3 supplementation in persons with prediabetes?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the safety and effectiveness of oral, high-dose daily vitamin D3 for the prevention of diabetes in adults at high risk for type 2 diabetes (T2D). The authors concluded that oral, high-dose daily vitamin D3 at a dose of 4000 IU was safe and well-tolerated in patients with prediabetes that were overweight or...

Read More

Evaluating the effectiveness of immunochemotherapy treatments for advanced stage follicular lymphoma.

Evaluating the effectiveness of immunochemotherapy treatments for advanced stage follicular lymphoma.

Posted by on May 31, 2022 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study compared the effectiveness of common immuno-chemotherapy (ICT) treatments for advanced follicular lymphoma (FL) for front-line therapy. The study showed that obinutuzumab (Gazyva; G) combined with bendamustine (Treanda; Benda) (G-Benda-G regimen) had the best survival without cancer worsening in patients with advanced...

Read More

Infusion reactions and effectiveness of front-line obinutuzumab and chlorambucil for chronic lymphocytic leukemia

Infusion reactions and effectiveness of front-line obinutuzumab and chlorambucil for chronic lymphocytic leukemia

Posted by on May 31, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to investigate infusion reactions and the effectiveness of the combination of obinutuzumab (Gazyva) and chlorambucil (Leukeran) in patients with chronic lymphocytic leukemia (CLL).  This study concluded that first dose infusion reactions with obinutuzumab can be reduced by using chlorambucil first and by using a very...

Read More

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the link between metformin (Glucophage) use in hospitalized and non-hospitalized patients with diabetes and different outcomes due to coronavirus disease 2019 (COVID-19). The study showed that metformin use was associated with a protective effect in COVID-19 outcomes in patients with type 2 diabetes (T2D). Some...

Read More

How beneficial is cognitive motor dual-task training to patients with stroke?

How beneficial is cognitive motor dual-task training to patients with stroke?

Posted by on May 8, 2022 in Stroke | 0 comments

In a nutshell This study analyzed the impact of cognitive-motor dual-task training (CMDT) on patients with chronic stroke. The authors concluded that CMDT had beneficial effects on balance ability, gait, and upper limb function in patients with chronic stroke. Some background A stroke involves an interruption or slowing of blood flow and oxygen to the...

Read More